Clover Biopharmaceuticals applies for PH COVID-19 vaccine trials

Chinese company Clover Biopharmaceuticals has applied to conduct Phase 3 clinical trials for its coronavirus vaccine in the Philippines.

FDA Director General Eric Domingo announced that Clover submitted its data to the Vaccine Expert Panel (VEP) for evaluation.

Domingo noted that he could not provide more details as of Friday.

The VEP is also reviewing an application from Clover Biopharmaceuticals, mistakenly referred to as an Australian company in earlier reports.